Screener
Praxis Precision Medicines, Inc. PRAX Business Segments — Personnel-related expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLaborRelatedExpenses.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Relutrigine | 13,979 | 10,509 | 26,833 | 15,886 |
| Elsunersen | 8,141 | 1,317 | 11,338 | 2,078 |
| Other early stage assets | 5,471 | 1,417 | 8,713 | 2,522 |
| Personnel-related expenses | 18,943 | 11,913 | 36,673 | 24,943 |
| Stock-based compensation expense | 11,309 | 7,770 | 28,421 | 16,556 |
| Depreciation expense | 33 | 46 | 72 | 93 |
| Other segment expenses(a) | 12,851 | 6,753 | 24,940 | 15,129 |
| Other income, net | 13,184 | 4,940 | 26,483 | 10,372 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s business segments — personnel-related expenses?
- Praxis Precision Medicines, Inc. (PRAX) reported business segments — personnel-related expenses of $18.94M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s business segments — personnel-related expenses changed year-over-year?
- Praxis Precision Medicines, Inc.'s business segments — personnel-related expenses increased by 59.0% year-over-year, from $11.91M to $18.94M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s business segments — personnel-related expenses?
- Over 2 years (2023 to 2025), Praxis Precision Medicines, Inc.'s business segments — personnel-related expenses has grown at a 39.7% compound annual growth rate (CAGR), from $33.16M to $64.72M.
- What does business segments — personnel-related expenses mean?
- This metric represents the total costs associated with employee compensation, including salaries, benefits, and payroll taxes within the primary business segment. It reflects the investment in human capital required to drive clinical development and research operations. Monitoring these costs helps assess the company's operational scale and organizational growth.
Ask your AI about Praxis Precision Medicines, Inc.'s business segments — personnel-related expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude